Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » Brisbane NET Patient Forum

Brisbane NET Patient Forum

  • September 24, 2019

(report by Meredith Cummins – NSW Project Officer)

On Tuesday 27 August a NET Patient Forum was held in the evening at the Cancer Council’s Auditorium in Fortitude Valley. We had a wonderful attendance for this Forum with approximately 80 registered for the event. Looking around the auditorium it was wonderful to see most seats filled – from the previous forum 2 years ago the attendance had doubled. We may need to look for a bigger venue in 2 years.

The guest speakers for the evening covered a diverse range of topics about Neuroendocrine Tumours. The first speaker was A/Prof David Wyld (Medical Oncologist) who gave an overview of the incidence of NET internationally, nationally and locally in Queensland.  A/Prof David Pattison (Nuclear Medicine Specialist and Endocrinologist) then spoke about current treatment with PRRT (Peptide Receptor Radionuclide Therapy).  The next speaker was Dr Amanda Love (Endocrinologist) who discussed Hereditary Syndromes which included Pheochromocytoma, Paraganglioma and MEN (Multiple Endocrine Neoplasias).  We then had Prof Jane Turner (Psychiatrist) speak about the Psychological Impact of Living with NETs – the roller coaster experience for patients and significant others, detailing coping mechanisms and seeking help in dealing with this. Rebecca Fichera (Dietitian) provided a very comprehensive presentation about diet, vitamin deficiencies and malabsorption issue. 

We then opened the floor up for a Question and Answer session with the panel of speakers including Louise Gordon, a Health Economist, who provided an update of the results from the Financial Toxicity study. Many questions were asked of the panel which was very beneficial for the attendees as some questions were asked which many had not thought to ask.

We then finalized the evening with an update on the Unicorn Foundations activities by Kate Wakelin and Cancer Council Queensland’s services by Carien Rees, Manager CCQld.

The feedback from the attendees has been very positive and we are so pleased to have been able to organize a successful evening in Brisbane. We have had the event filmed so this will soon be available on the Unicorn Foundation YouTube channel for all to watch. 

A huge thank you to Cancer Council Queensland, for enabling us to use the Auditorium for the Forum. 

Share this post

Recent posts

VHL Awareness Month 2025

May 6, 2025

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

May 5, 2025

Help Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact

April 29, 2025

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

April 5, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousCanberra NET Patient Forum
NextInternational Journal of Cancer PublicationNext

Related Posts

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of

Help Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact

NeuroEndocrine Cancer Australia (NECA) is proud to be the voice for thousands of Australians living with Neuroendocrine Cancer (NETs). But to do more — reach

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

Jo O’Halloran was in her early fifties when the symptoms she and her friends had heard so much about started to appear. ‘I was always

Parliament House representation for Federal Budget briefings

NECA attends the Treasurer’s Speech at Parliament House and then Medicines Australia Patient Organisation Brief at the Press Club on Wednesday 26 March 2025. The

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin